224 related articles for article (PubMed ID: 26491284)
1. A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease.
Fushida S; Oyama K; Kaji M; Hirono Y; Kinoshita J; Tsukada T; Nezuka H; Nakano T; Noto M; Nishijima K; Fujimura T; Ohta T
Int J Chron Obstruct Pulmon Dis; 2015; 10():2177-83. PubMed ID: 26491284
[TBL] [Abstract][Full Text] [Related]
2. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
Beeh KM; Derom E; Echave-Sustaeta J; Grönke L; Hamilton A; Zhai D; Bjermer L
Int J Chron Obstruct Pulmon Dis; 2016; 11():193-205. PubMed ID: 26893551
[TBL] [Abstract][Full Text] [Related]
3. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
5. The Design of and Rationale for the Effect of Perioperative Inhaled Tiotropium for Patients with Chronic Obstructive Pulmonary Disease in Esophageal Cancer Surgery (EPITOPE): an Open-Label, Randomized, Parallel-Group Study.
Okamura A; Watanabe M; Kitazono S; Manoshiro H; Kasama E; Takahashi K; Toihata T; Otake R; Kozuki R; Imamura Y; Yamahara Y; Ishizuka N
Eur Surg Res; 2020; 61(4-5):123-129. PubMed ID: 32248190
[TBL] [Abstract][Full Text] [Related]
6. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
[TBL] [Abstract][Full Text] [Related]
7. Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.
Calverley PM; Rennard SI; Clerisme-Beaty E; Metzdorf N; Zubek VB; ZuWallack R
Respir Res; 2016 Mar; 17():27. PubMed ID: 26971242
[TBL] [Abstract][Full Text] [Related]
8. Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.
Kobayashi S; Suzuki S; Niikawa H; Sugawara T; Yanai M
Respirology; 2009 Jul; 14(5):675-9. PubMed ID: 19476597
[TBL] [Abstract][Full Text] [Related]
9. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
[TBL] [Abstract][Full Text] [Related]
10. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
Bateman ED; van Dyk M; Sagriotis A
Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
[TBL] [Abstract][Full Text] [Related]
11. Effect of tiotropium on heart rate variability in stable chronic obstructive pulmonary disease patients.
Wu YK; Huang CY; Yang MC; Huang GL; Chen SY; Lan CC
J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):100-5. PubMed ID: 24840562
[TBL] [Abstract][Full Text] [Related]
12. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.
Jahnz-Różyk K; Szepiel P
Int J Chron Obstruct Pulmon Dis; 2015; 10():613-23. PubMed ID: 25834420
[TBL] [Abstract][Full Text] [Related]
13. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
Manoharan A; Morrison AE; Lipworth BJ
Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
[TBL] [Abstract][Full Text] [Related]
14. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.
Decramer ML; Chapman KR; Dahl R; Frith P; Devouassoux G; Fritscher C; Cameron R; Shoaib M; Lawrence D; Young D; McBryan D;
Lancet Respir Med; 2013 Sep; 1(7):524-33. PubMed ID: 24461613
[TBL] [Abstract][Full Text] [Related]
15. [A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease].
Yin KS; Zhang DP; Shi Y; Sun LH; Min R; Xiao YL; Xia XR; Tan Y; Fu WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):519-23. PubMed ID: 20979799
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of perioperative administration of long-acting bronchodilator on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease. Preliminary results of a randomized control study.
Suzuki H; Sekine Y; Yoshida S; Suzuki M; Shibuya K; Takiguchi Y; Tatsumi K; Yoshino I
Surg Today; 2010 Oct; 40(10):923-30. PubMed ID: 20872194
[TBL] [Abstract][Full Text] [Related]
18. Determinants of Long-Term Persistence with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease.
Tanaka K; Kamiishi N; Miyata J; Kabata H; Masaki K; Ogura-Tomomatsu H; Tomomatsu K; Suzuki Y; Fukunaga K; Sayama K; Betsuyaku T; Asano K
COPD; 2015 Jun; 12(3):233-9. PubMed ID: 25093464
[TBL] [Abstract][Full Text] [Related]
19. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
[TBL] [Abstract][Full Text] [Related]
20. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]